Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$12.93 - $18.45 $616,554 - $879,769
-47,684 Reduced 94.59%
2,727 $39,000
Q1 2024

Apr 25, 2024

SELL
$14.37 - $16.46 $96,853 - $110,940
-6,740 Reduced 11.79%
50,411 $820,000
Q4 2023

Jan 29, 2024

SELL
$8.6 - $14.94 $65,282 - $113,409
-7,591 Reduced 11.73%
57,151 $851,000
Q3 2023

Oct 17, 2023

BUY
$9.81 - $12.62 $635,119 - $817,044
64,742 New
64,742 $727,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Friedenthal Financial Portfolio

Follow Friedenthal Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friedenthal Financial, based on Form 13F filings with the SEC.

News

Stay updated on Friedenthal Financial with notifications on news.